Skip to main content
NewslettersWatchlist

Thermo Fisher Scientific Inc(TMO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low554.20
Day High565.88
Open:565.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
the globe and mail
the globe and mail

Why this money manager owns health care supply company Thermo Fisher Scientific and recently sold Nike

Daymon Loeb of Ravenstone Capital Management in Toronto, also owns Canadian Pacific Kansas City, Canadian National Railway and cable-connector giant Amphenol
Barchart
Stocks Fall on Higher Bond Yields and Mixed Earnings
Motley Fool
Thermo Fisher Scientific (TMO) Q3 2024 Earnings Call Transcript
Barchart
Nasdaq Futures Fall on Higher Bond Yields Ahead of Tesla Earnings
Newswire.ca
Exploring New Frontiers in Food Allergy Treatments: Market Set for $14B Growth
Motley Fool
Thermo Fisher Scientific (TMO) Q2 2024 Earnings Call Transcript
Barchart
Nasdaq Futures Plunge as U.S. Tech Earnings Disappoint, PMI Data in Focus
Motley Fool
Thermo Fisher Scientific (TMO) Q1 2024 Earnings Call Transcript
Baystreet
New Home Sales Due Next Week in Canada
Barchart
Stocks Slump as Fed Signals No Rush to Cut Interest Rates
Motley Fool
Thermo Fisher Scientific (TMO) Q4 2023 Earnings Call Transcript
Barchart
Stocks Slide as Tech Earnings Disappoint
Barchart
Nasdaq Futures Plunge as Big Tech Earnings Disappoint, Fed Rate Decision Looms
GlobeNewswire
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
Barchart
Stocks Finish Mixed as a Slump in Intel Weighs on the Overall Market
Barchart
Broader Market Gains on Goldilocks U.S. Economy
Motley Fool
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
The Globe and Mail
Nine Canadian fund managers offer their top picks and portfolio advice for 2024
Motley Fool
Down 19% in 2023 So Far, Is Thermo Fisher Scientific Stock Still Worth Buying?
Motley Fool
3 Beaten-Down Dividend Stocks You Could Regret Not Buying on the Dip
Motley Fool
Thermo Fisher Scientific (TMO) Q3 2023 Earnings Call Transcript
Barchart
Big Tech Losses Weigh on Overall Market as Alphabet Slumps
Barchart
Markets Today: Stocks Under Pressure as Alphabet Earnings Disappoint

Profile

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.